This research study is evaluating the safety and efficacy of administering venetoclax and
inotuzumab ozogamicin in combination in patients with acute lymphoblastic leukemia (ALL)
The names of the study drugs involved in this study are:
- Venetoclax
- Inotuzumab ozogamicin
- Dexamethasone